Table of Content

1 Tumor Necrosis Factor Receptor Superfamily Member 18 Market Overview
1.1 Product Overview and Scope of Tumor Necrosis Factor Receptor Superfamily Member 18
1.2 Tumor Necrosis Factor Receptor Superfamily Member 18 Segment by Type
1.2.1 Global Tumor Necrosis Factor Receptor Superfamily Member 18 Market Value Comparison by Type (2024-2034)
1.2.2 AMG-228
1.2.3 BMS-986156
1.2.4 FPA-154
1.2.5 GWN-323
1.2.6 INCAGN-1876
1.2.7 Others
1.3 Tumor Necrosis Factor Receptor Superfamily Member 18 Segment by Application
1.3.1 Global Tumor Necrosis Factor Receptor Superfamily Member 18 Market Value by Application: (2024-2034)
1.3.2 Melanoma
1.3.3 Non-Small Cell Lung Cancer
1.3.4 Gastric Cancer
1.3.5 Blood Cancer
1.3.6 Others
1.4 Global Tumor Necrosis Factor Receptor Superfamily Member 18 Market Size Estimates and Forecasts
1.4.1 Global Tumor Necrosis Factor Receptor Superfamily Member 18 Revenue 2018-2034
1.4.2 Global Tumor Necrosis Factor Receptor Superfamily Member 18 Sales 2018-2034
1.4.3 Global Tumor Necrosis Factor Receptor Superfamily Member 18 Market Average Price (2018-2034)
1.5 Assumptions and Limitations
2 Tumor Necrosis Factor Receptor Superfamily Member 18 Market Competition by Manufacturers
2.1 Global Tumor Necrosis Factor Receptor Superfamily Member 18 Sales Market Share by Manufacturers (2018-2024)
2.2 Global Tumor Necrosis Factor Receptor Superfamily Member 18 Revenue Market Share by Manufacturers (2018-2024)
2.3 Global Tumor Necrosis Factor Receptor Superfamily Member 18 Average Price by Manufacturers (2018-2024)
2.4 Global Tumor Necrosis Factor Receptor Superfamily Member 18 Industry Ranking 2021 VS 2022 VS 2024
2.5 Global Key Manufacturers of Tumor Necrosis Factor Receptor Superfamily Member 18, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Tumor Necrosis Factor Receptor Superfamily Member 18, Product Type & Application
2.7 Tumor Necrosis Factor Receptor Superfamily Member 18 Market Competitive Situation and Trends
2.7.1 Tumor Necrosis Factor Receptor Superfamily Member 18 Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Tumor Necrosis Factor Receptor Superfamily Member 18 Players Market Share by Revenue
2.7.3 Global Tumor Necrosis Factor Receptor Superfamily Member 18 Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Tumor Necrosis Factor Receptor Superfamily Member 18 Retrospective Market Scenario by Region
3.1 Global Tumor Necrosis Factor Receptor Superfamily Member 18 Market Size by Region: 2018 Versus 2022 Versus 2034
3.2 Global Tumor Necrosis Factor Receptor Superfamily Member 18 Global Tumor Necrosis Factor Receptor Superfamily Member 18 Sales by Region: 2018-2034
3.2.1 Global Tumor Necrosis Factor Receptor Superfamily Member 18 Sales by Region: 2018-2024
3.2.2 Global Tumor Necrosis Factor Receptor Superfamily Member 18 Sales by Region: 2024-2034
3.3 Global Tumor Necrosis Factor Receptor Superfamily Member 18 Global Tumor Necrosis Factor Receptor Superfamily Member 18 Revenue by Region: 2018-2034
3.3.1 Global Tumor Necrosis Factor Receptor Superfamily Member 18 Revenue by Region: 2018-2024
3.3.2 Global Tumor Necrosis Factor Receptor Superfamily Member 18 Revenue by Region: 2024-2034
3.4 North America Tumor Necrosis Factor Receptor Superfamily Member 18 Market Facts & Figures by Country
3.4.1 North America Tumor Necrosis Factor Receptor Superfamily Member 18 Market Size by Country: 2018 VS 2022 VS 2034
3.4.2 North America Tumor Necrosis Factor Receptor Superfamily Member 18 Sales by Country (2018-2034)
3.4.3 North America Tumor Necrosis Factor Receptor Superfamily Member 18 Revenue by Country (2018-2034)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Tumor Necrosis Factor Receptor Superfamily Member 18 Market Facts & Figures by Country
3.5.1 Europe Tumor Necrosis Factor Receptor Superfamily Member 18 Market Size by Country: 2018 VS 2022 VS 2034
3.5.2 Europe Tumor Necrosis Factor Receptor Superfamily Member 18 Sales by Country (2018-2034)
3.5.3 Europe Tumor Necrosis Factor Receptor Superfamily Member 18 Revenue by Country (2018-2034)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Tumor Necrosis Factor Receptor Superfamily Member 18 Market Facts & Figures by Country
3.6.1 Asia Pacific Tumor Necrosis Factor Receptor Superfamily Member 18 Market Size by Country: 2018 VS 2022 VS 2034
3.6.2 Asia Pacific Tumor Necrosis Factor Receptor Superfamily Member 18 Sales by Country (2018-2034)
3.6.3 Asia Pacific Tumor Necrosis Factor Receptor Superfamily Member 18 Revenue by Country (2018-2034)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Tumor Necrosis Factor Receptor Superfamily Member 18 Market Facts & Figures by Country
3.7.1 Latin America Tumor Necrosis Factor Receptor Superfamily Member 18 Market Size by Country: 2018 VS 2022 VS 2034
3.7.2 Latin America Tumor Necrosis Factor Receptor Superfamily Member 18 Sales by Country (2018-2034)
3.7.3 Latin America Tumor Necrosis Factor Receptor Superfamily Member 18 Revenue by Country (2018-2034)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Tumor Necrosis Factor Receptor Superfamily Member 18 Market Facts & Figures by Country
3.8.1 Middle East and Africa Tumor Necrosis Factor Receptor Superfamily Member 18 Market Size by Country: 2018 VS 2022 VS 2034
3.8.2 Middle East and Africa Tumor Necrosis Factor Receptor Superfamily Member 18 Sales by Country (2018-2034)
3.8.3 Middle East and Africa Tumor Necrosis Factor Receptor Superfamily Member 18 Revenue by Country (2018-2034)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Tumor Necrosis Factor Receptor Superfamily Member 18 Sales by Type (2018-2034)
4.1.1 Global Tumor Necrosis Factor Receptor Superfamily Member 18 Sales by Type (2018-2024)
4.1.2 Global Tumor Necrosis Factor Receptor Superfamily Member 18 Sales by Type (2024-2034)
4.1.3 Global Tumor Necrosis Factor Receptor Superfamily Member 18 Sales Market Share by Type (2018-2034)
4.2 Global Tumor Necrosis Factor Receptor Superfamily Member 18 Revenue by Type (2018-2034)
4.2.1 Global Tumor Necrosis Factor Receptor Superfamily Member 18 Revenue by Type (2018-2024)
4.2.2 Global Tumor Necrosis Factor Receptor Superfamily Member 18 Revenue by Type (2024-2034)
4.2.3 Global Tumor Necrosis Factor Receptor Superfamily Member 18 Revenue Market Share by Type (2018-2034)
4.3 Global Tumor Necrosis Factor Receptor Superfamily Member 18 Price by Type (2018-2034)
5 Segment by Application
5.1 Global Tumor Necrosis Factor Receptor Superfamily Member 18 Sales by Application (2018-2034)
5.1.1 Global Tumor Necrosis Factor Receptor Superfamily Member 18 Sales by Application (2018-2024)
5.1.2 Global Tumor Necrosis Factor Receptor Superfamily Member 18 Sales by Application (2024-2034)
5.1.3 Global Tumor Necrosis Factor Receptor Superfamily Member 18 Sales Market Share by Application (2018-2034)
5.2 Global Tumor Necrosis Factor Receptor Superfamily Member 18 Revenue by Application (2018-2034)
5.2.1 Global Tumor Necrosis Factor Receptor Superfamily Member 18 Revenue by Application (2018-2024)
5.2.2 Global Tumor Necrosis Factor Receptor Superfamily Member 18 Revenue by Application (2024-2034)
5.2.3 Global Tumor Necrosis Factor Receptor Superfamily Member 18 Revenue Market Share by Application (2018-2034)
5.3 Global Tumor Necrosis Factor Receptor Superfamily Member 18 Price by Application (2018-2034)
6 Key Companies Profiled
6.1 Ablynx NV
6.1.1 Ablynx NV Corporation Information
6.1.2 Ablynx NV Description and Business Overview
6.1.3 Ablynx NV Tumor Necrosis Factor Receptor Superfamily Member 18 Sales, Revenue and Gross Margin (2018-2024)
6.1.4 Ablynx NV Tumor Necrosis Factor Receptor Superfamily Member 18 Product Portfolio
6.1.5 Ablynx NV Recent Developments/Updates
6.2 Amgen Inc
6.2.1 Amgen Inc Corporation Information
6.2.2 Amgen Inc Description and Business Overview
6.2.3 Amgen Inc Tumor Necrosis Factor Receptor Superfamily Member 18 Sales, Revenue and Gross Margin (2018-2024)
6.2.4 Amgen Inc Tumor Necrosis Factor Receptor Superfamily Member 18 Product Portfolio
6.2.5 Amgen Inc Recent Developments/Updates
6.3 Apogenix GmbH
6.3.1 Apogenix GmbH Corporation Information
6.3.2 Apogenix GmbH Description and Business Overview
6.3.3 Apogenix GmbH Tumor Necrosis Factor Receptor Superfamily Member 18 Sales, Revenue and Gross Margin (2018-2024)
6.3.4 Apogenix GmbH Tumor Necrosis Factor Receptor Superfamily Member 18 Product Portfolio
6.3.5 Apogenix GmbH Recent Developments/Updates
6.4 Bristol-Myers Squibb Company
6.4.1 Bristol-Myers Squibb Company Corporation Information
6.4.2 Bristol-Myers Squibb Company Description and Business Overview
6.4.3 Bristol-Myers Squibb Company Tumor Necrosis Factor Receptor Superfamily Member 18 Sales, Revenue and Gross Margin (2018-2024)
6.4.4 Bristol-Myers Squibb Company Tumor Necrosis Factor Receptor Superfamily Member 18 Product Portfolio
6.4.5 Bristol-Myers Squibb Company Recent Developments/Updates
6.5 Five Prime Therapeutics Inc
6.5.1 Five Prime Therapeutics Inc Corporation Information
6.5.2 Five Prime Therapeutics Inc Description and Business Overview
6.5.3 Five Prime Therapeutics Inc Tumor Necrosis Factor Receptor Superfamily Member 18 Sales, Revenue and Gross Margin (2018-2024)
6.5.4 Five Prime Therapeutics Inc Tumor Necrosis Factor Receptor Superfamily Member 18 Product Portfolio
6.5.5 Five Prime Therapeutics Inc Recent Developments/Updates
6.6 Incyte Corp
6.6.1 Incyte Corp Corporation Information
6.6.2 Incyte Corp Description and Business Overview
6.6.3 Incyte Corp Tumor Necrosis Factor Receptor Superfamily Member 18 Sales, Revenue and Gross Margin (2018-2024)
6.6.4 Incyte Corp Tumor Necrosis Factor Receptor Superfamily Member 18 Product Portfolio
6.6.5 Incyte Corp Recent Developments/Updates
6.7 MedImmune LLC
6.6.1 MedImmune LLC Corporation Information
6.6.2 MedImmune LLC Description and Business Overview
6.6.3 MedImmune LLC Tumor Necrosis Factor Receptor Superfamily Member 18 Sales, Revenue and Gross Margin (2018-2024)
6.4.4 MedImmune LLC Tumor Necrosis Factor Receptor Superfamily Member 18 Product Portfolio
6.7.5 MedImmune LLC Recent Developments/Updates
6.8 Merck & Co Inc
6.8.1 Merck & Co Inc Corporation Information
6.8.2 Merck & Co Inc Description and Business Overview
6.8.3 Merck & Co Inc Tumor Necrosis Factor Receptor Superfamily Member 18 Sales, Revenue and Gross Margin (2018-2024)
6.8.4 Merck & Co Inc Tumor Necrosis Factor Receptor Superfamily Member 18 Product Portfolio
6.8.5 Merck & Co Inc Recent Developments/Updates
6.9 Novartis AG
6.9.1 Novartis AG Corporation Information
6.9.2 Novartis AG Description and Business Overview
6.9.3 Novartis AG Tumor Necrosis Factor Receptor Superfamily Member 18 Sales, Revenue and Gross Margin (2018-2024)
6.9.4 Novartis AG Tumor Necrosis Factor Receptor Superfamily Member 18 Product Portfolio
6.9.5 Novartis AG Recent Developments/Updates
6.10 OncoMed Pharmaceuticals Inc
6.10.1 OncoMed Pharmaceuticals Inc Corporation Information
6.10.2 OncoMed Pharmaceuticals Inc Description and Business Overview
6.10.3 OncoMed Pharmaceuticals Inc Tumor Necrosis Factor Receptor Superfamily Member 18 Sales, Revenue and Gross Margin (2018-2024)
6.10.4 OncoMed Pharmaceuticals Inc Tumor Necrosis Factor Receptor Superfamily Member 18 Product Portfolio
6.10.5 OncoMed Pharmaceuticals Inc Recent Developments/Updates
6.11 Regeneron Pharmaceuticals Inc
6.11.1 Regeneron Pharmaceuticals Inc Corporation Information
6.11.2 Regeneron Pharmaceuticals Inc Tumor Necrosis Factor Receptor Superfamily Member 18 Description and Business Overview
6.11.3 Regeneron Pharmaceuticals Inc Tumor Necrosis Factor Receptor Superfamily Member 18 Sales, Revenue and Gross Margin (2018-2024)
6.11.4 Regeneron Pharmaceuticals Inc Tumor Necrosis Factor Receptor Superfamily Member 18 Product Portfolio
6.11.5 Regeneron Pharmaceuticals Inc Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Tumor Necrosis Factor Receptor Superfamily Member 18 Industry Chain Analysis
7.2 Tumor Necrosis Factor Receptor Superfamily Member 18 Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Tumor Necrosis Factor Receptor Superfamily Member 18 Production Mode & Process
7.4 Tumor Necrosis Factor Receptor Superfamily Member 18 Sales and Marketing
7.4.1 Tumor Necrosis Factor Receptor Superfamily Member 18 Sales Channels
7.4.2 Tumor Necrosis Factor Receptor Superfamily Member 18 Distributors
7.5 Tumor Necrosis Factor Receptor Superfamily Member 18 Customers
8 Tumor Necrosis Factor Receptor Superfamily Member 18 Market Dynamics
8.1 Tumor Necrosis Factor Receptor Superfamily Member 18 Industry Trends
8.2 Tumor Necrosis Factor Receptor Superfamily Member 18 Market Drivers
8.3 Tumor Necrosis Factor Receptor Superfamily Member 18 Market Challenges
8.4 Tumor Necrosis Factor Receptor Superfamily Member 18 Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

List of Figure

List of Tables
Table 1. Global Tumor Necrosis Factor Receptor Superfamily Member 18 Market Value Comparison by Type (2024-2034) & (US$ Million)
Table 2. Global Tumor Necrosis Factor Receptor Superfamily Member 18 Market Value Comparison by Application (2024-2034) & (US$ Million)
Table 3. Global Tumor Necrosis Factor Receptor Superfamily Member 18 Market Competitive Situation by Manufacturers in 2022
Table 4. Global Tumor Necrosis Factor Receptor Superfamily Member 18 Sales (K Pcs) of Key Manufacturers (2018-2024)
Table 5. Global Tumor Necrosis Factor Receptor Superfamily Member 18 Sales Market Share by Manufacturers (2018-2024)
Table 6. Global Tumor Necrosis Factor Receptor Superfamily Member 18 Revenue (US$ Million) by Manufacturers (2018-2024)
Table 7. Global Tumor Necrosis Factor Receptor Superfamily Member 18 Revenue Share by Manufacturers (2018-2024)
Table 8. Global Market Tumor Necrosis Factor Receptor Superfamily Member 18 Average Price (USD/Pcs) of Key Manufacturers (2018-2024)
Table 9. Global Key Players of Tumor Necrosis Factor Receptor Superfamily Member 18, Industry Ranking, 2021 VS 2022 VS 2024
Table 10. Global Key Manufacturers of Tumor Necrosis Factor Receptor Superfamily Member 18, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Tumor Necrosis Factor Receptor Superfamily Member 18, Product Type & Application
Table 12. Global Key Manufacturers of Tumor Necrosis Factor Receptor Superfamily Member 18, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Tumor Necrosis Factor Receptor Superfamily Member 18 by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Tumor Necrosis Factor Receptor Superfamily Member 18 as of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Tumor Necrosis Factor Receptor Superfamily Member 18 Market Size by Region (US$ Million): 2018 VS 2022 VS 2034
Table 17. Global Tumor Necrosis Factor Receptor Superfamily Member 18 Sales by Region (2018-2024) & (K Pcs)
Table 18. Global Tumor Necrosis Factor Receptor Superfamily Member 18 Sales Market Share by Region (2018-2024)
Table 19. Global Tumor Necrosis Factor Receptor Superfamily Member 18 Sales by Region (2024-2034) & (K Pcs)
Table 20. Global Tumor Necrosis Factor Receptor Superfamily Member 18 Sales Market Share by Region (2024-2034)
Table 21. Global Tumor Necrosis Factor Receptor Superfamily Member 18 Revenue by Region (2018-2024) & (US$ Million)
Table 22. Global Tumor Necrosis Factor Receptor Superfamily Member 18 Revenue Market Share by Region (2018-2024)
Table 23. Global Tumor Necrosis Factor Receptor Superfamily Member 18 Revenue by Region (2024-2034) & (US$ Million)
Table 24. Global Tumor Necrosis Factor Receptor Superfamily Member 18 Revenue Market Share by Region (2024-2034)
Table 25. North America Tumor Necrosis Factor Receptor Superfamily Member 18 Revenue by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 26. North America Tumor Necrosis Factor Receptor Superfamily Member 18 Sales by Country (2018-2024) & (K Pcs)
Table 27. North America Tumor Necrosis Factor Receptor Superfamily Member 18 Sales by Country (2024-2034) & (K Pcs)
Table 28. North America Tumor Necrosis Factor Receptor Superfamily Member 18 Revenue by Country (2018-2024) & (US$ Million)
Table 29. North America Tumor Necrosis Factor Receptor Superfamily Member 18 Revenue by Country (2024-2034) & (US$ Million)
Table 30. Europe Tumor Necrosis Factor Receptor Superfamily Member 18 Revenue by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 31. Europe Tumor Necrosis Factor Receptor Superfamily Member 18 Sales by Country (2018-2024) & (K Pcs)
Table 32. Europe Tumor Necrosis Factor Receptor Superfamily Member 18 Sales by Country (2024-2034) & (K Pcs)
Table 33. Europe Tumor Necrosis Factor Receptor Superfamily Member 18 Revenue by Country (2018-2024) & (US$ Million)
Table 34. Europe Tumor Necrosis Factor Receptor Superfamily Member 18 Revenue by Country (2024-2034) & (US$ Million)
Table 35. Asia Pacific Tumor Necrosis Factor Receptor Superfamily Member 18 Revenue by Region: 2018 VS 2022 VS 2034 (US$ Million)
Table 36. Asia Pacific Tumor Necrosis Factor Receptor Superfamily Member 18 Sales by Region (2018-2024) & (K Pcs)
Table 37. Asia Pacific Tumor Necrosis Factor Receptor Superfamily Member 18 Sales by Region (2024-2034) & (K Pcs)
Table 38. Asia Pacific Tumor Necrosis Factor Receptor Superfamily Member 18 Revenue by Region (2018-2024) & (US$ Million)
Table 39. Asia Pacific Tumor Necrosis Factor Receptor Superfamily Member 18 Revenue by Region (2024-2034) & (US$ Million)
Table 40. Latin America Tumor Necrosis Factor Receptor Superfamily Member 18 Revenue by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 41. Latin America Tumor Necrosis Factor Receptor Superfamily Member 18 Sales by Country (2018-2024) & (K Pcs)
Table 42. Latin America Tumor Necrosis Factor Receptor Superfamily Member 18 Sales by Country (2024-2034) & (K Pcs)
Table 43. Latin America Tumor Necrosis Factor Receptor Superfamily Member 18 Revenue by Country (2018-2024) & (US$ Million)
Table 44. Latin America Tumor Necrosis Factor Receptor Superfamily Member 18 Revenue by Country (2024-2034) & (US$ Million)
Table 45. Middle East & Africa Tumor Necrosis Factor Receptor Superfamily Member 18 Revenue by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 46. Middle East & Africa Tumor Necrosis Factor Receptor Superfamily Member 18 Sales by Country (2018-2024) & (K Pcs)
Table 47. Middle East & Africa Tumor Necrosis Factor Receptor Superfamily Member 18 Sales by Country (2024-2034) & (K Pcs)
Table 48. Middle East & Africa Tumor Necrosis Factor Receptor Superfamily Member 18 Revenue by Country (2018-2024) & (US$ Million)
Table 49. Middle East & Africa Tumor Necrosis Factor Receptor Superfamily Member 18 Revenue by Country (2024-2034) & (US$ Million)
Table 50. Global Tumor Necrosis Factor Receptor Superfamily Member 18 Sales (K Pcs) by Type (2018-2024)
Table 51. Global Tumor Necrosis Factor Receptor Superfamily Member 18 Sales (K Pcs) by Type (2024-2034)
Table 52. Global Tumor Necrosis Factor Receptor Superfamily Member 18 Sales Market Share by Type (2018-2024)
Table 53. Global Tumor Necrosis Factor Receptor Superfamily Member 18 Sales Market Share by Type (2024-2034)
Table 54. Global Tumor Necrosis Factor Receptor Superfamily Member 18 Revenue (US$ Million) by Type (2018-2024)
Table 55. Global Tumor Necrosis Factor Receptor Superfamily Member 18 Revenue (US$ Million) by Type (2024-2034)
Table 56. Global Tumor Necrosis Factor Receptor Superfamily Member 18 Revenue Market Share by Type (2018-2024)
Table 57. Global Tumor Necrosis Factor Receptor Superfamily Member 18 Revenue Market Share by Type (2024-2034)
Table 58. Global Tumor Necrosis Factor Receptor Superfamily Member 18 Price (USD/Pcs) by Type (2018-2024)
Table 59. Global Tumor Necrosis Factor Receptor Superfamily Member 18 Price (USD/Pcs) by Type (2024-2034)
Table 60. Global Tumor Necrosis Factor Receptor Superfamily Member 18 Sales (K Pcs) by Application (2018-2024)
Table 61. Global Tumor Necrosis Factor Receptor Superfamily Member 18 Sales (K Pcs) by Application (2024-2034)
Table 62. Global Tumor Necrosis Factor Receptor Superfamily Member 18 Sales Market Share by Application (2018-2024)
Table 63. Global Tumor Necrosis Factor Receptor Superfamily Member 18 Sales Market Share by Application (2024-2034)
Table 64. Global Tumor Necrosis Factor Receptor Superfamily Member 18 Revenue (US$ Million) by Application (2018-2024)
Table 65. Global Tumor Necrosis Factor Receptor Superfamily Member 18 Revenue (US$ Million) by Application (2024-2034)
Table 66. Global Tumor Necrosis Factor Receptor Superfamily Member 18 Revenue Market Share by Application (2018-2024)
Table 67. Global Tumor Necrosis Factor Receptor Superfamily Member 18 Revenue Market Share by Application (2024-2034)
Table 68. Global Tumor Necrosis Factor Receptor Superfamily Member 18 Price (USD/Pcs) by Application (2018-2024)
Table 69. Global Tumor Necrosis Factor Receptor Superfamily Member 18 Price (USD/Pcs) by Application (2024-2034)
Table 70. Ablynx NV Corporation Information
Table 71. Ablynx NV Description and Business Overview
Table 72. Ablynx NV Tumor Necrosis Factor Receptor Superfamily Member 18 Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 73. Ablynx NV Tumor Necrosis Factor Receptor Superfamily Member 18 Product
Table 74. Ablynx NV Recent Developments/Updates
Table 75. Amgen Inc Corporation Information
Table 76. Amgen Inc Description and Business Overview
Table 77. Amgen Inc Tumor Necrosis Factor Receptor Superfamily Member 18 Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 78. Amgen Inc Tumor Necrosis Factor Receptor Superfamily Member 18 Product
Table 79. Amgen Inc Recent Developments/Updates
Table 80. Apogenix GmbH Corporation Information
Table 81. Apogenix GmbH Description and Business Overview
Table 82. Apogenix GmbH Tumor Necrosis Factor Receptor Superfamily Member 18 Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 83. Apogenix GmbH Tumor Necrosis Factor Receptor Superfamily Member 18 Product
Table 84. Apogenix GmbH Recent Developments/Updates
Table 85. Bristol-Myers Squibb Company Corporation Information
Table 86. Bristol-Myers Squibb Company Description and Business Overview
Table 87. Bristol-Myers Squibb Company Tumor Necrosis Factor Receptor Superfamily Member 18 Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 88. Bristol-Myers Squibb Company Tumor Necrosis Factor Receptor Superfamily Member 18 Product
Table 89. Bristol-Myers Squibb Company Recent Developments/Updates
Table 90. Five Prime Therapeutics Inc Corporation Information
Table 91. Five Prime Therapeutics Inc Description and Business Overview
Table 92. Five Prime Therapeutics Inc Tumor Necrosis Factor Receptor Superfamily Member 18 Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 93. Five Prime Therapeutics Inc Tumor Necrosis Factor Receptor Superfamily Member 18 Product
Table 94. Five Prime Therapeutics Inc Recent Developments/Updates
Table 95. Incyte Corp Corporation Information
Table 96. Incyte Corp Description and Business Overview
Table 97. Incyte Corp Tumor Necrosis Factor Receptor Superfamily Member 18 Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 98. Incyte Corp Tumor Necrosis Factor Receptor Superfamily Member 18 Product
Table 99. Incyte Corp Recent Developments/Updates
Table 100. MedImmune LLC Corporation Information
Table 101. MedImmune LLC Description and Business Overview
Table 102. MedImmune LLC Tumor Necrosis Factor Receptor Superfamily Member 18 Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 103. MedImmune LLC Tumor Necrosis Factor Receptor Superfamily Member 18 Product
Table 104. MedImmune LLC Recent Developments/Updates
Table 105. Merck & Co Inc Corporation Information
Table 106. Merck & Co Inc Description and Business Overview
Table 107. Merck & Co Inc Tumor Necrosis Factor Receptor Superfamily Member 18 Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 108. Merck & Co Inc Tumor Necrosis Factor Receptor Superfamily Member 18 Product
Table 109. Merck & Co Inc Recent Developments/Updates
Table 110. Novartis AG Corporation Information
Table 111. Novartis AG Description and Business Overview
Table 112. Novartis AG Tumor Necrosis Factor Receptor Superfamily Member 18 Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 113. Novartis AG Tumor Necrosis Factor Receptor Superfamily Member 18 Product
Table 114. Novartis AG Recent Developments/Updates
Table 115. OncoMed Pharmaceuticals Inc Corporation Information
Table 116. OncoMed Pharmaceuticals Inc Description and Business Overview
Table 117. OncoMed Pharmaceuticals Inc Tumor Necrosis Factor Receptor Superfamily Member 18 Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 118. OncoMed Pharmaceuticals Inc Tumor Necrosis Factor Receptor Superfamily Member 18 Product
Table 119. OncoMed Pharmaceuticals Inc Recent Developments/Updates
Table 120. Regeneron Pharmaceuticals Inc Corporation Information
Table 121. Regeneron Pharmaceuticals Inc Description and Business Overview
Table 122. Regeneron Pharmaceuticals Inc Tumor Necrosis Factor Receptor Superfamily Member 18 Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 123. Regeneron Pharmaceuticals Inc Tumor Necrosis Factor Receptor Superfamily Member 18 Product
Table 124. Regeneron Pharmaceuticals Inc Recent Developments/Updates
Table 125. Key Raw Materials Lists
Table 126. Raw Materials Key Suppliers Lists
Table 127. Tumor Necrosis Factor Receptor Superfamily Member 18 Distributors List
Table 128. Tumor Necrosis Factor Receptor Superfamily Member 18 Customers List
Table 129. Tumor Necrosis Factor Receptor Superfamily Member 18 Market Trends
Table 130. Tumor Necrosis Factor Receptor Superfamily Member 18 Market Drivers
Table 131. Tumor Necrosis Factor Receptor Superfamily Member 18 Market Challenges
Table 132. Tumor Necrosis Factor Receptor Superfamily Member 18 Market Restraints
Table 133. Research Programs/Design for This Report
Table 134. Key Data Information from Secondary Sources
Table 135. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Tumor Necrosis Factor Receptor Superfamily Member 18
Figure 2. Global Tumor Necrosis Factor Receptor Superfamily Member 18 Market Value Comparison by Type (2024-2034) & (US$ Million)
Figure 3. Global Tumor Necrosis Factor Receptor Superfamily Member 18 Market Share by Type in 2022 & 2034
Figure 4. AMG-228 Product Picture
Figure 5. BMS-986156 Product Picture
Figure 6. FPA-154 Product Picture
Figure 7. GWN-323 Product Picture
Figure 8. INCAGN-1876 Product Picture
Figure 9. Others Product Picture
Figure 10. Global Tumor Necrosis Factor Receptor Superfamily Member 18 Market Value Comparison by Application (2024-2034) & (US$ Million)
Figure 11. Global Tumor Necrosis Factor Receptor Superfamily Member 18 Market Share by Application in 2022 & 2034
Figure 12. Melanoma
Figure 13. Non-Small Cell Lung Cancer
Figure 14. Gastric Cancer
Figure 15. Blood Cancer
Figure 16. Others
Figure 17. Global Tumor Necrosis Factor Receptor Superfamily Member 18 Revenue, (US$ Million), 2018 VS 2022 VS 2034
Figure 18. Global Tumor Necrosis Factor Receptor Superfamily Member 18 Market Size (2018-2034) & (US$ Million)
Figure 19. Global Tumor Necrosis Factor Receptor Superfamily Member 18 Sales (2018-2034) & (K Pcs)
Figure 20. Global Tumor Necrosis Factor Receptor Superfamily Member 18 Average Price (USD/Pcs) & (2018-2034)
Figure 21. Tumor Necrosis Factor Receptor Superfamily Member 18 Report Years Considered
Figure 22. Tumor Necrosis Factor Receptor Superfamily Member 18 Sales Share by Manufacturers in 2022
Figure 23. Global Tumor Necrosis Factor Receptor Superfamily Member 18 Revenue Share by Manufacturers in 2022
Figure 24. The Global 5 and 10 Largest Tumor Necrosis Factor Receptor Superfamily Member 18 Players: Market Share by Revenue in 2022
Figure 25. Tumor Necrosis Factor Receptor Superfamily Member 18 Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 26. Global Tumor Necrosis Factor Receptor Superfamily Member 18 Market Size by Region (US$ Million): 2018 VS 2022 VS 2034
Figure 27. North America Tumor Necrosis Factor Receptor Superfamily Member 18 Sales Market Share by Country (2018-2034)
Figure 28. North America Tumor Necrosis Factor Receptor Superfamily Member 18 Revenue Market Share by Country (2018-2034)
Figure 29. U.S. Tumor Necrosis Factor Receptor Superfamily Member 18 Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 30. Canada Tumor Necrosis Factor Receptor Superfamily Member 18 Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 31. Europe Tumor Necrosis Factor Receptor Superfamily Member 18 Sales Market Share by Country (2018-2034)
Figure 32. Europe Tumor Necrosis Factor Receptor Superfamily Member 18 Revenue Market Share by Country (2018-2034)
Figure 33. Germany Tumor Necrosis Factor Receptor Superfamily Member 18 Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 34. France Tumor Necrosis Factor Receptor Superfamily Member 18 Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 35. U.K. Tumor Necrosis Factor Receptor Superfamily Member 18 Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 36. Italy Tumor Necrosis Factor Receptor Superfamily Member 18 Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 37. Russia Tumor Necrosis Factor Receptor Superfamily Member 18 Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 38. Asia Pacific Tumor Necrosis Factor Receptor Superfamily Member 18 Sales Market Share by Region (2018-2034)
Figure 39. Asia Pacific Tumor Necrosis Factor Receptor Superfamily Member 18 Revenue Market Share by Region (2018-2034)
Figure 40. China Tumor Necrosis Factor Receptor Superfamily Member 18 Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 41. Japan Tumor Necrosis Factor Receptor Superfamily Member 18 Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 42. South Korea Tumor Necrosis Factor Receptor Superfamily Member 18 Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 43. India Tumor Necrosis Factor Receptor Superfamily Member 18 Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 44. Australia Tumor Necrosis Factor Receptor Superfamily Member 18 Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 45. Taiwan Tumor Necrosis Factor Receptor Superfamily Member 18 Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 46. Indonesia Tumor Necrosis Factor Receptor Superfamily Member 18 Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 47. Thailand Tumor Necrosis Factor Receptor Superfamily Member 18 Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 48. Malaysia Tumor Necrosis Factor Receptor Superfamily Member 18 Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 49. Philippines Tumor Necrosis Factor Receptor Superfamily Member 18 Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 50. Latin America Tumor Necrosis Factor Receptor Superfamily Member 18 Sales Market Share by Country (2018-2034)
Figure 51. Latin America Tumor Necrosis Factor Receptor Superfamily Member 18 Revenue Market Share by Country (2018-2034)
Figure 52. Mexico Tumor Necrosis Factor Receptor Superfamily Member 18 Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 53. Brazil Tumor Necrosis Factor Receptor Superfamily Member 18 Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 54. Argentina Tumor Necrosis Factor Receptor Superfamily Member 18 Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 55. Middle East & Africa Tumor Necrosis Factor Receptor Superfamily Member 18 Sales Market Share by Country (2018-2034)
Figure 56. Middle East & Africa Tumor Necrosis Factor Receptor Superfamily Member 18 Revenue Market Share by Country (2018-2034)
Figure 57. Turkey Tumor Necrosis Factor Receptor Superfamily Member 18 Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 58. Saudi Arabia Tumor Necrosis Factor Receptor Superfamily Member 18 Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 59. U.A.E Tumor Necrosis Factor Receptor Superfamily Member 18 Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 60. Global Sales Market Share of Tumor Necrosis Factor Receptor Superfamily Member 18 by Type (2018-2034)
Figure 61. Global Revenue Market Share of Tumor Necrosis Factor Receptor Superfamily Member 18 by Type (2018-2034)
Figure 62. Global Tumor Necrosis Factor Receptor Superfamily Member 18 Price (USD/Pcs) by Type (2018-2034)
Figure 63. Global Sales Market Share of Tumor Necrosis Factor Receptor Superfamily Member 18 by Application (2018-2034)
Figure 64. Global Revenue Market Share of Tumor Necrosis Factor Receptor Superfamily Member 18 by Application (2018-2034)
Figure 65. Global Tumor Necrosis Factor Receptor Superfamily Member 18 Price (USD/Pcs) by Application (2018-2034)
Figure 66. Tumor Necrosis Factor Receptor Superfamily Member 18 Value Chain
Figure 67. Tumor Necrosis Factor Receptor Superfamily Member 18 Production Process
Figure 68. Channels of Distribution (Direct Vs Distribution)
Figure 69. Distributors Profiles
Figure 70. Bottom-up and Top-down Approaches for This Report
Figure 71. Data Triangulation
Figure 72. Key Executives Interviewed